Circumventing qPCR inhibition to amplify miRNAs in plasma

[1]  Gabriel Rinaldi,et al.  Distinct miRNA signatures associate with subtypes of cholangiocarcinoma from infection with the tumourigenic liver fluke Opisthorchis viverrini. , 2014, Journal of hepatology.

[2]  P. Brindley,et al.  Circumventing qPCR inhibition to amplify miRNAs in plasma , 2014, Biomarker Research.

[3]  P. Levine,et al.  Methods and matrices: approaches to identifying miRNAs for Nasopharyngeal carcinoma , 2014, Journal of Translational Medicine.

[4]  A. Loukas,et al.  The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer. , 2012, Trends in parasitology.

[5]  S. Sleijfer,et al.  Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients , 2011, Expert review of molecular diagnostics.

[6]  A. Casadevall,et al.  Correlation between Serum and Plasma Antibody Titers to Mycobacterial Antigens , 2010, Clinical and Vaccine Immunology.

[7]  M. L. Hastings,et al.  Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells , 2010, PloS one.

[8]  Tongyu Lin,et al.  Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression , 2010, Journal of gastroenterology and hepatology.

[9]  Hsien-Da Huang,et al.  microRNA: a master regulator of cellular processes for bioengineering systems. , 2010, Annual review of biomedical engineering.

[10]  Paul Bertone,et al.  Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. , 2010, RNA.

[11]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[12]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[13]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[14]  C. Navanukraw,et al.  Heparinase treatment of RNA before quantitative real-time RT-PCR. , 2003, BioTechniques.

[15]  C. Burge,et al.  The microRNAs of Caenorhabditis elegans. , 2003, Genes & development.

[16]  D. Ginzinger.  Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. , 2002, Experimental hematology.

[17]  J. Blanco,et al.  Anticoagulants Interfere with PCR Used To Diagnose Invasive Aspergillosis , 2002, Journal of Clinical Microbiology.

[18]  S. Keshavjee,et al.  Heparin interference with reverse transcriptase polymerase chain reaction of RNA extracted from lungs after ischemia-reperfusion , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[19]  N. Harada,et al.  Regulation of Placenta-specific Expression of the Aromatase Cytochrome P-450 Gene , 1995, The Journal of Biological Chemistry.

[20]  K. Yoshida,et al.  Isolation of the porcine heparin tetrasaccharides with glucuronate 2-O-sulfate. Heparinase cleaves glucuronate 2-O-sulfate-containing disaccharides in highly sulfated blocks in heparin. , 1995, The Journal of biological chemistry.

[21]  R. Linhardt,et al.  Structure of heparin-derived tetrasaccharides. , 1985, The Biochemical journal.

[22]  Hansjuerg Alder,et al.  The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. , 2009, Gynecologic oncology.